Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in man
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (5) , 761-766
- https://doi.org/10.1016/0006-2952(86)90243-1
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Dazoxiben, a thromboxane synthetase inhibitor, in the treatment of Raynaud's syndrome: a double-blind trial.Published by Wiley ,1983
- Thromboxane Mediation of Cardiopulmonary Effects of EmbolismJournal of Clinical Investigation, 1982
- PLASMA THROMBOXANE CONCENTRATIONS ARE RAISED IN PATIENTS DYING WITH SEPTIC SHOCKThe Lancet, 1982
- Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic rabbit kidney.Circulation Research, 1982
- URINE i-TXB2 IN RENAL ALLOGRAFT REJECTIONThe Lancet, 1981
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Bronchoconstriction by histamine and bradykinin in guinea pigs: Relationship to thromboxane A2 generation and the effect of aspirinProstaglandins, 1980
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- Diversion of prostaglandin endoperoxide metabolism by selective inhibition of thromboxane A2 biosynthesis in lung, spleen or plateletsEuropean Journal of Pharmacology, 1977
- : A selective inhibitor of thromboxane synthetaseProstaglandins, 1977